Global Immunohematology Market Size, Trends, and Growth Opportunity, By Technology (Biochips, Erythrocyte-Magnetized Technology (EMT), and Gel Cards), By Product Type (Reagents, and Analyzers (Automatic and Semi-automatic/Manual)), By End User (Blood Banks, Diagnostic and Reference Laboratories, and Hospitals), By Region and Forecast to 2030.
Global Immunohematology Market 
The Global Immunohematology Market was valued at USD 2.57 million in 2022 and is expected to reach USD 4.16 million by 2030, at a CAGR 5.16% during the forecast period 2023- 2030.
The study of antibodies in the plasma and antigens in blood cells is known as image Antigens in blood cells and antibodies in plasma are studied in immunohematology. In blood cells, there are over 230 different antigen types that are divided into two groups depending on their chemical makeup. Polypeptides and carbs are what they are. ABO and RhD blood group testing is required for the patient receiving the transfusion. Antibodies will also be examined for presence. Plasma and donor blood cells may react as a result. There are numerous tests available to find and identify the antibody present in the patient, ranging from straightforward tube assays to gel tests to elution procedures, etc. The antigen found in a patient's blood cell will also be identified by the same test.
Market Drivers
The creation of cutting-edge technology for blood screening and the introduction of new goods. The desire of hospitals and diagnostic laboratories for automated instrumentation and the fusion of several operations onto a single platform is accelerating the expansion. Industry participants are investing more money in R&D, which is helping the industry expand. 
Additionally, the market is noticing a growing emphasis on corporate diversification. Mergers and acquisitions are vital approaches used by important industry players as an expansion strategy since they are dynamic. Blood banks are becoming more popular and could boost sales of immunohematology equipment. 
Market Restraints
The market expansion may be hampered by high maintenance costs and little consumer knowledge of these goods' availability in developing and underdeveloped economies. Some of the factors driving this market include the rise in the demand for immunohematology devices and the number of blood banks around the world. To develop a new solution, the corporation must make a significant investment in its R&D and technology divisions. All of these factors are hampering the market growth.
Market Segmentation
Global Immunohematology Market is segmented into Technology, Product Type, and End User.
Based on Technology, the market is divided into Biochips, Erythrocyte-Magnetized Technology (EMT), and Gel Cards.
Based on Product Type, the market is classified into Reagents, and Analyzers (Automatic and Semi-automatic/Manual). 
Based on End User, the market is bifurcated into Blood Banks, Diagnostic and Reference Laboratories, and Hospitals.
Regional Analysis
The Global Immunohematology Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.
With the high frequency of leukemia, the concentration of market players, and increasing government support for blood transfusions, the North American area currently dominates the global market. The United States' existing healthcare infrastructure and current clinical trials for the treatment of leukemia will also help to drive the market. 
In addition, the adoption of novel immunohematology technologies, rising healthcare costs, and shifting dynamics in the in vitro diagnostics industry are all likely to contribute to significant growth in the Asia Pacific region.
Key Players
Various key players are discussed in the Global Immunohematology Market Report including: Ortho Clinical Diagnostics, IMMUNOCOR, Abbott Laboratories, Siemens Healthineers, Grifols, Beckman Coulter, Thermo Fisher Scientific, Becton, and Dickinson and Company.
Market Taxonomy
By Technology 
• Biochips
• Erythrocyte-Magnetized Technology (EMT)
• Gel Cards
By Product Type 
• Reagents
• Analyzers (Automatic and Semi-automatic/Manual)
By End User
• Blood Banks
• Diagnostic and Reference Laboratories
• Hospitals
By Region
• North America 
• Latin America 
• Europe  
• Asia Pacific  
• Middle East & Africa

Global Immunohematology Market 
1 Introduction 
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Immunohematology Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn 
4.2.6 Post covid-19 world Supply & Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Immunohematology Market, By Technology 
5.1 Y-o-Y Growth Comparison, By Technology  
5.2 Global Immunohematology Market Share Analysis, By Technology  
5.3 Global Immunohematology Market Size and Forecast, By Technology 
5.3.1 Biochips
5.3.2 Erythrocyte-Magnetized Technology (EMT)
5.3.3 Gel Cards
6 Global Immunohematology Market, By Product Type
6.1 Y-o-Y Growth Comparison, By Product Type
6.2 Global Immunohematology Market Share Analysis, By Product Type
6.3 Global Immunohematology Market Size and Forecast, By Product Type
6.3.1 Reagents
6.3.2 Analyzers (Automatic and Semi-automatic/Manual)
7 Global Immunohematology Market, By End User
7.1 Y-o-Y Growth Comparison, By End User 
7.2 Global Immunohematology Market Share Analysis, By End User 
7.3 Global Immunohematology Market Size and Forecast, By End User 
7.3.1 Blood Banks
7.3.2 Diagnostic and Reference Laboratories
7.3.3 Hospitals
8 Global Immunohematology Market, By Region
8.1 Global Immunohematology Market Share Analysis, By Region
8.2 Global Immunohematology Market Size and Forecast, By Region
9 North America Immunohematology Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Immunohematology Market Share Analysis, By Technology  
9.3 North America Immunohematology Market Size and Forecast, By Product Type
9.4 North America Immunohematology Market Size and Forecast, By End User 
9.5 North America Immunohematology Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Immunohematology Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Immunohematology Market Share Analysis, By Technology  
10.3 Europe Immunohematology Market Size and Forecast, By Product Type
10.4 Europe Immunohematology Market Size and Forecast, By End User 
10.5 Europe Immunohematology Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4 Rest of Europe
11 Asia Pacific Immunohematology Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Immunohematology Market Share Analysis, By Technology  
11.3 Asia Pacific Immunohematology Market Size and Forecast, By Product Type
11.4 Asia Pacific Immunohematology Market Size and Forecast, By End User 
11.5 Asia Pacific Immunohematology Market Size and Forecast, By Country
11.5.1 China 
11.5.2 Japan
11.5.3 India
11.5.4 Rest of Asia Pacific
12 Latin America Immunohematology Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Immunohematology Market Share Analysis, By Technology  
12.3 Latin America Immunohematology Market Size and Forecast, By Product Type
12.4 Latin America Immunohematology Market Size and Forecast, By End User 
12.5 Latin America Immunohematology Market Size and Forecast, Country
12.5.1 Brazil
12.5.2 Rest of Latin America
13 Middle East Immunohematology Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East Immunohematology Market Share Analysis, By Technology  
13.3 Middle East Immunohematology Market Size and Forecast, By Product Type
13.4 Middle East Immunohematology Market Size and Forecast, By End User 
13.5 Middle East Immunohematology Market Size and Forecast, By Country
13.6.1 Saudi Arabia
13.5.2 UAE
13.5.3 Egypt
13.5.4 Kuwait
13.5.5 South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Ortho Clinical Diagnostics
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 IMMUNOCOR
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Abbott Laboratories
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Siemens Healthineers 
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Grifols
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Beckman Coulter
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Thermo Fisher Scientific
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Becton
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Dickinson and Company
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies